1 Min Read
Jan 11 (Reuters) - Celyad Sa
* Announces registration of first pancreatic cancer patient in its CAR-T NKR-2 THINK Trial in Belgium Source text: bit.ly/2jjM82G Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.